Condition
Apheresis
Total Trials
6
Recruiting
2
Active
2
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
Termination Rate
16.7%
1 terminated out of 6 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
75% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 4 (1)
Trial Status
Completed3
Recruiting2
Terminated1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT00001846Recruiting
Collection and Distribution of Blood Components From Healthy Donors for In Vitro Research Use
NCT04939805Not ApplicableRecruiting
CRP Apheresis in STEMI
NCT05191290Phase 4CompletedPrimary
Comparison of Biocompatibility of Plasmapheresis Procedures With Citrate and Heparin Anticoagulation
NCT04846374CompletedPrimary
Two is Better Than One: A Novel Venous Access System for Intermittent Apheresis
NCT00562601TerminatedPrimary
LCI Apheresis to Obtain Plasma or White Blood Cells
NCT00042627CompletedPrimary
Prevalence and Risk of Cataracts in Granulocyte Donors
Showing all 6 trials